2,4-DISUBSTITUTED PHENYLENE-1,5-DIAMINE DERIVATIVES AND APPLICATIONS THEREOF, AND PHARMACEUTICAL COMPOSITIONS AND PHARMACEUTICALLY ACCEPTABLE COMPOSITIONS PREPARED THEREFROM
申请人:SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO. LTD.
公开号:US20170008889A1
公开(公告)日:2017-01-12
The present invention provides a class of 2,4-substituted phenylene-1,5-diamine derivatives, having an inhibiting effect on EGFR tyrosine kinases, and pharmaceutically acceptable salt, stereoisomer, solvate or prodrug of said derivatives. See the description for the definition of each group in the formula. In addition, the present invention also discloses pharmaceutical compositions, pharmaceutically acceptable compositions and applications thereof.
本发明提供了一类2,4-取代苯基-1,5-二胺衍生物,对EGFR酪氨酸激酶具有抑制作用,并提供了该衍生物的药用可接受盐、立体异构体、溶剂合物或前药。有关每个组在公式中的定义,请参阅说明。此外,本发明还揭示了药物组合物、药用可接受组合物及其应用。